| The logopenic/phonological variant of primary progressive aphasia ML Gorno-Tempini, SM Brambati, V Ginex, J Ogar, NF Dronkers, ... Neurology 71 (16), 1227-1234, 2008 | 859 | 2008 |
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ... The Lancet Neurology 16 (8), 661-676, 2017 | 676 | 2017 |
| Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias G Chételat, J Arbizu, H Barthel, V Garibotto, I Law, S Morbelli, ... The Lancet Neurology 19 (11), 951-962, 2020 | 416 | 2020 |
| Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence V Garibotto, B Borroni, E Kalbe, K Herholz, E Salmon, V Holtoff, S Sorbi, ... Neurology 71 (17), 1342-1349, 2008 | 297 | 2008 |
| In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder D Perani, V Garibotto, A Gorini, RM Moresco, M Henin, A Panzacchi, ... Neuroimage 42 (1), 306-314, 2008 | 253 | 2008 |
| In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease S Iannaccone, C Cerami, M Alessio, V Garibotto, A Panzacchi, S Olivieri, ... Parkinsonism & related disorders 19 (1), 47-52, 2013 | 249 | 2013 |
| Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting D Perani, PA Della Rosa, C Cerami, F Gallivanone, F Fallanca, EG Vanoli, ... NeuroImage: Clinical 6, 445-454, 2014 | 231 | 2014 |
| A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease A Nordberg, SF Carter, J Rinne, A Drzezga, DJ Brooks, R Vandenberghe, ... European journal of nuclear medicine and molecular imaging 40, 104-114, 2013 | 227 | 2013 |
| Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD B Borroni, D Anchisi, B Paghera, B Vicini, N Kerrouche, V Garibotto, ... Neurobiology of aging 27 (1), 24-31, 2006 | 205 | 2006 |
| EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ... European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020 | 185 | 2020 |
| EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 E Guedj, A Varrone, R Boellaard, NL Albert, H Barthel, B van Berckel, ... European journal of nuclear medicine and molecular imaging, 1-20, 2022 | 170 | 2022 |
| Evidence of white matter changes on diffusion tensor imaging in frontotemporal dementia B Borroni, SM Brambati, C Agosti, S Gipponi, G Bellelli, R Gasparotti, ... Archives of neurology 64 (2), 246-251, 2007 | 168 | 2007 |
| Individual detection of patients with Parkinson disease using support vector machine analysis of diffusion tensor imaging data: initial results S Haller, S Badoud, D Nguyen, V Garibotto, KO Lovblad, PR Burkhard American Journal of Neuroradiology 33 (11), 2123-2128, 2012 | 137 | 2012 |
| Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease SP Caminiti, L Presotto, D Baroncini, V Garibotto, RM Moresco, L Gianolli, ... NeuroImage: Clinical 14, 734-740, 2017 | 134 | 2017 |
| Disorganization of anatomical connectivity in obsessive compulsive disorder: a multi-parameter diffusion tensor imaging study in a subpopulation of patients V Garibotto, P Scifo, A Gorini, CR Alonso, S Brambati, L Bellodi, D Perani Neurobiology of disease 37 (2), 468-476, 2010 | 130 | 2010 |
| Clinical applications of hybrid PET/MRI in neuroimaging V Garibotto, S Heinzer, S Vulliemoz, R Guignard, M Wissmeyer, M Seeck, ... Clinical nuclear medicine 38 (1), e13-e18, 2013 | 124 | 2013 |
| Yield of MRI, high-density electric source imaging (HD-ESI), SPECT and PET in epilepsy surgery candidates AM Lascano, T Perneger, S Vulliemoz, L Spinelli, V Garibotto, CM Korff, ... Clinical Neurophysiology 127 (1), 150-155, 2016 | 121 | 2016 |
| Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia Z Walker, F Gandolfo, S Orini, V Garibotto, F Agosta, J Arbizu, F Bouwman, ... European journal of nuclear medicine and molecular imaging 45, 1534-1545, 2018 | 120 | 2018 |
| The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers NJ Ashton, A Leuzy, TK Karikari, N Mattsson-Carlgren, A Dodich, ... European journal of nuclear medicine and molecular imaging 48, 2140-2156, 2021 | 117 | 2021 |
| Projection space implementation of deep learning–guided low-dose brain PET imaging improves performance over implementation in image space A Sanaat, H Arabi, I Mainta, V Garibotto, H Zaidi Journal of Nuclear Medicine 61 (9), 1388-1396, 2020 | 112 | 2020 |
